The Effects of Converting Enzyme Inhibition
Several compounds have been discovered or created that inhibit angiotensin converting enzyme and thereby dramatically slow the conversion of angiotensin I to angiotensin II. One of these, captopril, has been widely used as an experimental tool and is currently being evaluated for routine clinical use because it can be administered orally.
KeywordsArterial Pressure Angiotensin Converting Enzyme Converting Enzyme Plasma Renin Activity Renal Blood Flow
Unable to display preview. Download preview PDF.